Table 2 Correlation between clinicopathological parameters of 120 EAC patients and Silva system/SCS
From: Silva cumulative score and its relationship with prognosis in Endocervical adenocarcinoma
clinicopathological characteristics | total | Silva system | p | Silva cumulative score | p | ||||
|---|---|---|---|---|---|---|---|---|---|
pattern A | pattern B | pattern C | grade I (score2–3) | grade II (score 4–5) | grade III (score 6–7) | ||||
n | 120 (100) | 11 (9.2) | 22 (18.3) | 87 (72.5) | 23 (19.2) | 31 (25.8) | 66 (55.0) | ||
age | |||||||||
median | 48 (26–73) | 46 (35–65) | 45 (28–73) | 49 (26–69) | 0.541 | 46 (29–65) | 46 (26–73) | 51 (32–69) | 0.050 |
average | 47.98 ± 9.10 | 47.27 ± 10.46 | 46.18 ± 10.71 | 48.53 ± 8.52 | 46.35 ± 9.93 | 45.35 ± 9.63 | 49.79 ± 8.23 | ||
with HSIL | |||||||||
No | 103 (85.8) | 10 (90.9) | 18 (81.8) | 75 (86.2) | 0.830 | 19 (82.6) | 26 (83.9) | 58 (87.9) | 0.777 |
Yes | 17 (14.2) | 1 (9.1) | 4 (18.2) | 12 (13.8) | 4 (17.4) | 5 (16.1) | 8 (12.1) | ||
DOI | |||||||||
<1/2 | 51 (42.5) | 10 (90.9) | 13 (59.1) | 28 (32.2) | 0.000 | 20 (87.0) | 14 (45.2) | 17 (25.8) | 0.000 |
>1/2 | 69 (57.5) | 1 (9.1) | 9 (40.9) | 59 (67.8) | 3 (13.0) | 17 (54.8) | 49 (74.2) | ||
LVI | |||||||||
Negative | 68 (56.7) | 11 (100.0) | 16 (72.7) | 41 (47.1) | 0.000 | 23 (100) | 23 (74.2) | 22 (33.3) | 0.000 |
Positive | 52 (43.3) | 0 | 6 (27.3) | 46 (52.9) | 0 | 8 (25.8) | 44 (66.7) | ||
FIGO stage | |||||||||
I | 65 (54.2) | 10 (90.9) | 12 (54.5) | 43 (49.4) | 0.025 | 17 (73.9) | 21 (67.7) | 27 (40.9) | 0.001 |
II | 31 (25.8) | 1 (9.1) | 8 (36.4) | 22 (25.3) | 6 (26.1) | 7 (22.6) | 18 (27.3) | ||
III | 24 (20.0) | 0 | 2 (9.1) | 22 (25.3) | 0 | 3 (9.7) | 21 (31.8) | ||
LNM | |||||||||
Negative | 96 (80.0) | 11 (100.0) | 20 (90.9) | 65 (74.7) | 0.046 | 23 (100) | 28 (90.3) | 45 (68.2) | 0.001 |
Positive | 24 (20.0) | 0 | 2 (9.1) | 22 (25.3) | 0 | 3 (9.7) | 21 (31.8) | ||